Author

S. Tominaga

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1

Frequent Co-Authors

A. E. Carpenter· 1 shared H. Kitamura· 1 shared H. Segawa· 1 shared J. Jin· 1 shared J. Watanabe· 1 shared K. Ikeo· 1 shared K. Kadoya· 1 shared K. Nagahama· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. E. Carpenter

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Predicting gene expression from cell morphology in human induced pluripotent stem cells

T. Wakui, M. Negishi, Y. Murakami, S. Tominaga, Y. Shiraishi, A. E. Carpenter, S. Singh, H. Segawa

The paper builds a model to predict gene expression from cell morphology in hiPSCs and identifies two genes well-predicted by morphology.

bioRxiv · Apr 19, 2022 · PreprintBioengineering

Pirfenidone attenuates lung fibrotic fibroblast-mediated fibrotic responses to transforming growth factor-β1

J. Jin, S. Togo, K. Kadoya, m. tulafu, Y. Namba, M. Moe Iwai, J. Watanabe, K. Nagahama, T. Okabe, M. Hidayat, Y. Kodama, H. Kitamura, T. Ogura, N. Kitamura, K. Ikeo, , K. Takahashi

This study shows pirfenidone reduces fibrotic responses in lung fibroblasts by inhibiting CTHRC1, suggesting it as a potential therapeutic target for lung fibrosis.

bioRxiv · Aug 27, 2018Cell Biology